NEW YORK (GenomeWeb) – CombiMatrix announced today that it has entered into a contract with Blue Cross and Blue Shield of Illinois, the largest health plan in the state. Under the deal, BCBSIL members will have access to CombiMatrix's menu of CombiSNP microarray-based diagnostic testing services for developmental disorders and oncology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.